Core Points - The Bioeconomy Index (970038) closed at 2270.57 points, up 1.89%, with a trading volume of 27.083 billion yuan and a turnover rate of 1.74% [1] - Among the index constituents, 47 stocks rose, with Jiuan Medical leading at a 10.01% increase, while 3 stocks fell, with Furui Shares leading the decline at 1.75% [1] Index Constituents Summary - The top ten constituents of the Bioeconomy Index include: - Mindray Medical (sz300760) with a weight of 12.58%, latest price at 209.35 yuan, and a market cap of 253.825 billion yuan [1] - Changchun High-tech (sz000661) with a weight of 4.87%, latest price at 105.06 yuan, and a market cap of 42.858 billion yuan [1] - Shentou Aoshang (sz002252) with a weight of 4.74%, latest price at 6.91 yuan, and a market cap of 45.868 billion yuan [1] - Kanglong Chemical (sz300759) with a weight of 4.55%, latest price at 31.84 yuan, and a market cap of 56.618 billion yuan [1] - Tigermed (sz300347) with a weight of 4.54%, latest price at 60.00 yuan, and a market cap of 51.662 billion yuan [1] - Shenzhen Technology (sz000021) with a weight of 4.16%, latest price at 27.84 yuan, and a market cap of 43.753 billion yuan [1] - Muyuan Foods (sz002714) with a weight of 3.62%, latest price at 51.67 yuan, and a market cap of 282.261 billion yuan [1] - Lepu Medical (sz300003) with a weight of 3.19%, latest price at 17.00 yuan, and a market cap of 31.338 billion yuan [1] - Aimeike (sz300896) with a weight of 3.16%, latest price at 156.50 yuan, and a market cap of 47.356 billion yuan [1] - Yuyue Medical (sz002223) with a weight of 3.07%, latest price at 35.97 yuan, and a market cap of 36.059 billion yuan [1] Capital Flow Summary - The Bioeconomy Index constituents experienced a net inflow of 1.505 billion yuan from main funds, while retail funds saw a net outflow of 1.087 billion yuan [3] - Notable capital flows include: - Shenzhen Technology (000021) with a net inflow of 145.514 million yuan from main funds [3] - Jiuan Medical (002432) with a net inflow of 309 million yuan from main funds [3] - Mindray Medical (300760) with a net inflow of 203 million yuan from main funds [3] - Muyuan Foods (002714) with a net inflow of 145 million yuan from main funds [3] - Tigermed (300347) with a net inflow of 80.614 million yuan from main funds [3]

Group 1 - The average stock price of the Sci-Tech Innovation Board is 40.80 yuan, with 69 stocks priced over 100 yuan, and the highest priced stock is Cambrian-U at 1391.50 yuan [2][3] - Among the stocks priced over 100 yuan, 37 stocks increased in price today, with an average increase of 0.56%, while 32 stocks decreased [2][3] - The average premium of the latest closing price relative to the issue price for stocks over 100 yuan is 502.60%, with the highest premiums seen in companies like Shunwei New Materials and Cambrian-U [2][3] Group 2 - The net outflow of main funds for stocks over 100 yuan today totaled 3.607 billion yuan, with the highest net inflows seen in companies like Purun Co. and Tengjing Technology [3] - The total margin balance for stocks over 100 yuan is 94.857 billion yuan, with Cambrian-U and SMIC having the highest margin balances [3][4] - The stock list of companies over 100 yuan includes various sectors, with a concentration in electronics, pharmaceuticals, and computers [2][3]

Summary of Key Points Core Viewpoint - In the past 10 days (from October 28 to November 10), overseas institutions have conducted research on 271 listed companies, with Huaming Equipment being the most focused, receiving attention from 80 overseas institutions [1]. Group 1: Research Activity - A total of 788 companies were researched by institutions in the last 10 days, with securities companies conducting research on 742 companies, accounting for the majority [1]. - Fund companies followed with research on 631 companies, while overseas institutions visited 271 listed companies [1]. - Huaming Equipment led the overseas research list with 80 institutions participating, followed by United Imaging Healthcare with 62 institutions [1]. Group 2: Stock Performance - The average stock price of companies researched by overseas institutions increased by 1.02% over the past 10 days [1]. - Notable stock price increases included Tianji Shares, which rose by 74.96%, and Aters, which increased by 71.51% [1]. - Conversely, 141 stocks experienced declines, with Juguang Technology showing the largest drop at 18.08% [1]. Group 3: Detailed Stock Data - The table lists various companies, their stock codes, the number of overseas institutions that researched them, latest closing prices, percentage changes, and their respective industries [1][2][3][4][5][6][7][8][9]. - For example, Tianji Shares (002759) had 2 overseas institutions researching it, with a closing price of 39.82 yuan and a rise of 74.96% [1]. - Huaming Equipment (002270) was researched by 80 overseas institutions, with a closing price of 27.40 yuan and a rise of 9.69% [2].

Investment Rating - The report maintains a "Buy" rating for the company [4][7] Core Views - The company's revenue for the first three quarters of 2025 reached 231.88 billion yuan, a year-on-year increase of 14.85%, with net profit attributable to the parent company at 57.51 billion yuan, up 24.50% year-on-year [11] - The growth is driven by the continuous release of innovative drug research results and accelerated overseas licensing cooperation, contributing to incremental performance [11] - The company has strengthened its innovative pipeline, with significant product approvals and a robust pipeline in various therapeutic areas [11] Financial Performance Summary - Revenue (in million yuan): - 2023A: 22,820 - 2024A: 27,985 - 2025E: 34,184 - 2026E: 38,303 - 2027E: 43,925 - Year-on-year growth rates: 2024A: 22.6%, 2025E: 22.2%, 2026E: 12.0%, 2027E: 14.7% [6][13] - Net profit (in million yuan): - 2023A: 4,302 - 2024A: 6,337 - 2025E: 8,755 - 2026E: 10,043 - 2027E: 11,403 - Year-on-year growth rates: 2024A: 47.3%, 2025E: 38.2%, 2026E: 14.7%, 2027E: 13.5% [6][13] - Earnings per share (in yuan): - 2023A: 0.65 - 2024A: 0.95 - 2025E: 1.32 - 2026E: 1.51 - 2027E: 1.72 [6][13] Strategic Developments - The company has achieved significant overseas licensing agreements, with over 800 million USD in upfront payments in the first three quarters of 2025 [11] - Recent collaborations include agreements with GSK, Glenmark, and Braveheart Bio, indicating a strong push towards internationalization [11] - The company is focusing on expanding its innovative drug portfolio, with multiple new drug applications accepted by NMPA [11]

Core Insights - Recent market style has shifted, with growth assets experiencing a "pain period" as sectors like electronics and biopharmaceuticals have seen significant declines since October [1] - The current adjustment in the dual innovation sector is attributed to structural differentiation within the market, where previous substantial gains have led to elevated valuation levels, setting the stage for a correction [1] - Short-term corrections are viewed as healthy adjustments following rapid increases, with the PE ratio of the Sci-Tech Innovation 50 Index dropping from 67 times on October 9 to 57 times on October 31, indicating a valuation repair that could build momentum for the next market phase [1] - Positive catalysts are emerging both domestically and internationally, including policy support emphasizing "technological self-reliance," potential expansion of domestic monetary policy easing, and the rapid rise of emerging industries such as artificial intelligence, semiconductors, and innovative pharmaceuticals [1] Investment Opportunities - The Sci-Tech Innovation 50 ETF (588080), the Growth Enterprise Board ETF (159915), and the Sci-Tech Innovation and Growth ETF (159781) are leading in scale among their tracked indices, offering good liquidity and a management fee rate of 0.15% per year, making them convenient options for investors looking to capitalize on "Sci-Tech + Growth" opportunities [2]

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report Through macro - fundamental analysis and technical analysis using tools such as the Golden Section line, horizontal line, and moving average, the report provides forecasts for the trends of various futures contracts on November 10, 2025, and also offers monthly trend expectations for some futures contracts in November 2025 [2]. 3. Summary by Relevant Catalogs 3.1 Futures Market Overview - On November 10, 2025, stock index futures are expected to oscillate and consolidate; rebar, coking coal, glass, crude oil, and soybean meal futures are expected to oscillate weakly; lithium carbonate futures are expected to oscillate strongly [1]. 3.2 Stock Index Futures - On November 7, 2025, major stock index futures contracts such as IF2512, IH2512, IC2512, and IM2512 showed weak oscillations, with slightly increased short - term downward pressure. On November 10, they are expected to oscillate and consolidate, and in November 2025, they are expected to oscillate widely [20][28]. 3.3 Treasury Bond Futures - On November 7, 2025, the ten - year and thirty - year treasury bond futures contracts showed downward trends. On November 10, they are expected to oscillate weakly [46][52]. 3.4 Precious Metal Futures - On November 7, 2025, gold and silver futures contracts showed upward trends. In November 2025, they are expected to oscillate widely, and on November 10, gold futures are expected to oscillate and consolidate, while silver futures are expected to oscillate and consolidate as well [55][60]. 3.5 Base Metal Futures - On November 7, 2025, base metal futures contracts such as copper, aluminum, zinc, nickel, and tin showed different trends. In November 2025, some are expected to oscillate widely and strongly, while others are expected to oscillate widely and weakly. On November 10, their trends vary, with some oscillating and consolidating, some oscillating weakly, and some oscillating strongly [64][77]. 3.6 Energy and Chemical Futures - On November 7, 2025, energy and chemical futures contracts such as crude oil, fuel oil, PTA, PVC, and methanol showed different trends. In November 2025, they are expected to oscillate widely, and on November 10, most are expected to oscillate weakly [125][136]. 3.7 Agricultural Product Futures - On November 7, 2025, agricultural product futures contracts such as soybean meal, rapeseed meal, and natural rubber showed weak oscillations. On November 10, they are expected to oscillate weakly or widely [138][144]. 3.8 Macro - economic Information - China's foreign trade, foreign exchange reserves, CPI, PPI, and other economic data have different trends, and there are also international events such as the US government shutdown and policy adjustments in various countries [9][10]. 3.9 Commodity Futures - related Information - The CSRC has approved the registration of platinum, palladium futures, and options at the Guangzhou Futures Exchange. Indian gold ETFs have seen record - breaking capital inflows, and international precious metal and crude oil futures have different price trends [17][18].

- The report mentions the construction of enhanced strategy ETFs, which are based on indices such as CSI 300, CSI 500, CSI 1000, SSE STAR 50, and others. These ETFs aim to outperform their respective benchmarks through quantitative strategies and factor-based enhancements [23][24][35] - The construction process involves selecting stocks from the underlying index and applying quantitative models to optimize the portfolio. The models may include factor analysis, risk control, and return enhancement techniques. Specific formulas or methodologies are not detailed in the report [23][24][35] - Evaluation of enhanced strategy ETFs indicates that 18 out of 51 ETFs outperformed their benchmarks last week. Over the past year, 30 out of 33 ETFs achieved positive excess returns, showcasing the effectiveness of the strategy [23][24][35] - Testing results for enhanced strategy ETFs show varying excess returns. For example, the CSI 300 Enhanced ETF achieved a weekly excess return of 0.64%, while the CSI 500 Enhanced ETF achieved 1.42%. Over the past year, the CSI 1000 Enhanced ETF delivered an excess return of 28.67%, and the Guozheng 2000 Enhanced ETF achieved 33.35% [24][35][36]

Market Overview - On November 7, the Shanghai Composite Index fell by 0.25%, with the total margin financing balance at 24,936.93 billion yuan, a decrease of 5.156 billion yuan from the previous trading day [1] - The margin financing balance in the Shanghai market was 12,691.71 billion yuan, down by 4.511 billion yuan; in the Shenzhen market, it was 12,165.68 billion yuan, down by 0.642 billion yuan; and in the Beijing Stock Exchange, it was 7.954 billion yuan, down by 0.34182 million yuan [1] Industry Analysis - Among the industries tracked by Shenwan, 10 industries saw an increase in financing balance, with the power equipment industry leading with an increase of 4.031 billion yuan, followed by the communication and basic chemical industries with increases of 0.246 billion yuan and 0.201 billion yuan, respectively [1] Stock Performance - A total of 1,582 stocks experienced an increase in financing balance, accounting for 42.28% of the total, with 293 stocks seeing an increase of over 5% [1] - The stock with the largest increase in financing balance was Henghe Co., Ltd., with a latest financing balance of 1.8036 million yuan, reflecting a 91.02% increase from the previous trading day, and its stock price rose by 1.71% [1] - Other notable stocks with significant increases in financing balance included Solar Cable (002300) and Wanrun New Energy, with increases of 88.28% and 59.61%, respectively [1] Top Gainers and Losers - Among the top 20 stocks with the largest increase in financing balance, the average increase was 6.70%, with notable gainers including Dongyue Silicon Material (300821) at 20.04%, Zhuoyue New Energy at 20.01%, and Anda Technology at 16.36% [2] - Conversely, the largest decrease in financing balance was seen in Guangda Jiabao (600622), which dropped by 43.35%, with a latest financing balance of 198.09 million yuan [4] - Other stocks with significant decreases included Wanze Shares (000534) and Yinen Power, with declines of 33.40% and 30.87%, respectively [4] Detailed Stock Data - The top stocks with increased financing balances included: - Henghe Co., Ltd. (920145): 1.8036 million yuan, +91.02%, +1.71% [3] - Solar Cable (002300): 19,422.56 million yuan, +88.28%, -1.26% [3] - Wanrun New Energy (688275): 36,234.04 million yuan, +59.61%, +15.28% [3] - The top stocks with decreased financing balances included: - Guangda Jiabao (600622): 198.09 million yuan, -43.35%, -2.95% [4] - Wanze Shares (000534): 242.38 million yuan, -33.40%, +8.80% [4] - Yinen Power (920046): 11.11 million yuan, -30.87%, -2.97% [4]

Core Viewpoint - The Hong Kong stock market is expected to continue its volatile trend as year-end approaches, with a cautious risk appetite among investors. Key sectors to watch include cyclical stocks benefiting from rising downstream commodity prices, dividend stocks for defensive strategies, and sectors positively impacted by improving China-US trade relations [1][4]. Market Performance - During the week of November 3 to November 7, the Hong Kong stock market showed mixed results, with the Hang Seng Index rising by 1.29%, while the Technology Index fell by 1.20%, and the State-Owned Enterprises Index increased by 1.08% [2]. - Among the primary sectors, Energy, Financials, and Utilities saw the highest gains, with increases of 6.02%, 3.45%, and 3.14% respectively. Conversely, Healthcare, Consumer Discretionary, and Information Technology experienced declines of 3.05%, 1.80%, and 0.77% respectively [2]. Liquidity Analysis - The average daily trading volume on the Hong Kong Stock Exchange was HKD 230.53 billion, a decrease of HKD 49.99 billion from the previous week. The average short-selling amount was HKD 29.46 billion, down by HKD 2.08 billion, with short-selling accounting for 12.79% of the trading volume, an increase of 1.6 percentage points [2]. - Cumulative net inflow from southbound funds reached HKD 38.68 billion, an increase of HKD 11.19 billion compared to the previous week [2]. Valuation and Risk Appetite - As of November 7, the Hang Seng Index had a Price-to-Earnings (PE) ratio of 11.87 and a Price-to-Book (PB) ratio of 1.23, reflecting increases of 1.81% and 1.87% respectively, positioning it at the 85% and 88% percentile levels since 2019. The Hang Seng Technology Index had a PE of 22.69 and a PB of 3.30, at the 28% and 69% percentile levels respectively [3]. - The risk premium for the Hang Seng Index was calculated at 4.32%, which is -1.86 standard deviations from the 3-year rolling mean, placing it at the 6% percentile since 2010 [3]. Investment Outlook - Internationally, the U.S. Supreme Court raised questions about the legality of Trump's tariffs, leading to expectations of potential tariff reductions. In October, U.S. private sector employment increased by 42,000, significantly exceeding the expected 30,000 [4]. - Domestically, China's total goods trade value in October was CNY 3.7 trillion, a 0.1% increase, with exports at CNY 2.17 trillion (down 0.8%) and imports at CNY 1.53 trillion (up 1.4%) [4]. - The market is advised to focus on cyclical stocks due to changing supply-demand dynamics, dividend stocks for defensive positioning, and sectors benefiting from improved China-US trade relations [4].

Group 1 - US stock market saw a significant rebound from intraday lows on Friday, with the S&P 500 rising by 0.13% and the Dow Jones increasing by 0.16%, while the Nasdaq Composite fell by 0.22%, marking its worst weekly performance since April [1] - Microsoft experienced its longest losing streak since 2011, with eight consecutive declines, while Tesla dropped over 3.6% following the approval of Elon Musk's $1 trillion compensation plan at the shareholder meeting [2] - Gold fluctuated around $4,000, ending a two-week decline, while crude oil prices briefly rose above $60 but ultimately fell by over 1.7% for the week [3] Group 2 - Bitcoin briefly dipped below $100,000 but later surged over 4.6%, while Ethereum rose by over 4.3%, reclaiming the $3,400 mark [4] - The US government shutdown situation appears to be improving, with Democrats softening their stance, although Republicans have rejected the proposal but acknowledged progress [4] - The EU AI legislation may face pressure to lower its thresholds due to collective pressure from tech giants [5] Group 3 - Google launched its next-generation AI image model, Nano Banana 2, capable of quickly generating 4K images and solving calculus problems [6] - The Chinese government issued a document to accelerate the cultivation of scenarios and promote large-scale applications in the AI field, focusing on key technology breakthroughs and standard construction [7] - A white paper on carbon peak and carbon neutrality in China indicated that the proportion of non-fossil energy consumption is expected to increase from 16.0% in 2020 to 19.8% in 2024 [8] Group 4 - The People's Bank of China increased its gold reserves by 30,000 ounces in October, marking the 12th consecutive month of increases [10] - China's October CPI rose by 0.2% year-on-year, with the core CPI reaching its highest level since March 2024, while the PPI saw its first year-on-year increase of the year [11] Group 5 - Various brokerage strategies are focusing on year-end style rebalancing, with analysts suggesting that sectors like new energy, pharmaceuticals, and food and beverage may show weaker performance as they face profit-taking pressures [12] - Analysts recommend focusing on sectors with independent logic and improving ROE, such as chemicals, non-ferrous metals, and electric new energy, which are at historical low points in profitability and industry prosperity [13] Group 6 - NAND flash memory prices are set to increase significantly, with SanDisk raising contract prices by up to 50%, leading to some manufacturers pausing shipments to reassess pricing [14] - The flu activity in China has risen sharply, with most provinces entering the flu epidemic period, prompting increased production of antiviral medications [16] - The Ministry of Agriculture and Rural Affairs released guidelines for building a smart agriculture standard system, aiming for a comprehensive standard system by 2030 [17] - The smart agriculture market in China is projected to exceed 100 billion yuan in 2024, growing by 11.7% year-on-year, driven by policy support and increased fiscal investment [18] Group 7 - Several companies announced significant transactions, including Suzhou planning to acquire 100% of Dongjin Hangke for 250 million yuan, and Guocheng Mining proposing to pay 3.168 billion yuan for a 60% stake in Guocheng Industrial [19] - Huadian Energy plans to invest 12.043 billion yuan in a wind power project, while Huadian Science and Technology signed a contract for a major offshore wind power project [20] - Fangzheng Technology is investing 1.364 billion yuan to expand its AI production base in Chongqing, addressing capacity bottlenecks in high-end products [21]